Location History:
- Ibaraki-Ken, JP (2012)
- Tsukuba, JP (2009 - 2013)
Company Filing History:
Years Active: 2009-2013
Title: Tomoko Sekiya: Innovator in GPR Research
Introduction
Tomoko Sekiya is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of biomedical research, particularly in the area of G protein-coupled receptors (GPCRs). With a total of 3 patents, her work focuses on developing methods for screening substances that can influence cell-stimulating activities.
Latest Patents
One of her latest patents is titled "Method for screening of substance which alter GPR120-mediated cell-stimulating activities." This invention provides a screening method to determine whether a substance of interest can alter GPR120-mediated cell-stimulating activities. The method involves using a biomembrane containing GPR120 or cells with said biomembrane, along with phospholipase or its salts. This screening method can identify substances like CCK and GLP-1, which are involved in hormone secretion in the gastrointestinal tract.
Another significant patent is "Method of screening substance useful in treating disease with the use of GPR40 and phospholipase." This invention relates to a screening method for determining whether a substance can alter GPR40-mediated cell-stimulating activities. It also utilizes a biomembrane containing GPR40 or cells with said biomembrane, along with phospholipase or its salts. This method can screen substances that may be useful in preventing or treating various diseases, including diabetes and its complications.
Career Highlights
Tomoko Sekiya is currently employed at Eisai R&D Management Co., Ltd., where she continues her innovative research. Her work has garnered attention for its potential applications in treating metabolic disorders and other health issues.
Collaborations
She collaborates with notable colleagues, including Norimasa Miyamoto and Hirokazu Tanaka, who contribute to her research endeavors.
Conclusion
Tomoko Sekiya's contributions to the field of biomedical research, particularly in GPCRs, highlight her role as an influential inventor. Her innovative screening methods have the potential to advance the treatment of various diseases, showcasing the importance of her work in the scientific community.